Performance analysis of Seres Therapeutics (MCRB)
Annual Return
Over the past 3 years, MCRB has had an average annual return of -61.61%, underperforming the benchmark SPY, which returned +19.62% annual.
Over the past 5 years, MCRB has had an average annual return of -49.48%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, MCRB has had an average annual return of -38.62%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Jun 26, 2015, MCRB has had an average annual return of -37.91%, underperforming the benchmark SPY, which returned +14.03% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -64.83% | -10.49% | -40.44% | -75.02% | -32.82% | -66.00% | +610.43% | -23.66% | -55.45% | +2.44% | -71.79% | -31.73% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0% | -41.38% | +1.18% | -16.28% | -1.39% | +8.45% | -33.77% | -64.83% | |||||
| 2025 | +1.23% | -9.76% | -8.11% | -30.88% | -26.60% | +56.52% | +28.70% | +32.37% | +1.63% | -16.04% | +11.46% | -17.14% | -10.49% |
| 2024 | -19.12% | +0.91% | -31.98% | +27.81% | +1.04% | -27.69% | +85.11% | -40.23% | +17.95% | -13.59% | +20.13% | -15.18% | -40.44% |
| 2023 | -2.30% | -7.71% | +12.32% | -14.05% | +1.58% | -3.22% | +0.43% | -28.31% | -31.00% | -35.64% | -32.21% | +34.65% | -75.02% |
| 2022 | +0.12% | -4.13% | -10.99% | -33.57% | -34.46% | +10.61% | +19.94% | +25% | +24.90% | +38.03% | -26.62% | -13.91% | -32.82% |
| 2021 | -3.06% | -19.84% | +8.15% | +1.07% | +1.43% | +12.98% | -70.24% | -9.70% | +8.58% | -12.63% | +76.92% | -22.55% | -66.00% |
| 2020 | -5.51% | -3.63% | +13.75% | +3.02% | +49.16% | -13.30% | -21.38% | +607.97% | +6.87% | -1.49% | -1.00% | -11.26% | +610.43% |
| 2019 | +36.29% | -0.42% | +12.07% | -4.86% | -47.88% | -5.58% | -15.18% | +47.65% | -0.51% | -12.69% | +12.78% | -12.63% | -23.66% |
| 2018 | -0.41% | -5.95% | -22.73% | +4.48% | +4.96% | +6.83% | -11.95% | +15.95% | -13.52% | -9.48% | +21.54% | -45.91% | -55.45% |
| 2017 | -0.10% | -2.13% | +16.46% | -12.81% | -7.22% | +23.90% | +19.75% | +3.72% | +14.32% | -37.42% | +4.61% | -3.43% | +2.44% |
Drawdown analysis of Seres Therapeutics (MCRB)
The maximum drawdown for the MCRB was -99.50%, occurring on Jul 16, 2026. This drawdown has not yet recovered.
The current MCRB drawdown is -99.49%.
Since Jun 26, 2015 MCRB has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.50% | Jun 26, 2015 | 2778 | Jul 16, 2026 | Ongoing | Ongoing | Ongoing |